VIA Folio Processes Closing for Myomo, the First Exchange-Traded Reg A+ IPO
VIA Folio is pleased to announce that it has processed the closing of Myomo’s Reg A+ IPO, the first of its kind to be traded on a national exchange. Read more >>
28Jun
Related Posts
01Sep
More kids are going to the ER for swallowing ‘button’ batteries, study finds. Why that’s really dangerous
More than 70,000 children in the past decade went to the emergency room for swallowing batteries, a new study found,... read more
25Feb
Elizabeth Banks Has Been Sending Her ‘Manny’ Easy Recipes to Make: ‘He’s Never Really Cooked
Elizabeth Banks is sharing her love of food with her "manny." The Hunger Games star, 50, who hosted a happy... read more
01Aug
EcoSoul Home: A Visionary Journey towards Sustainable Living
In the bustling city of Boston, USA, two visionaries named Rahul Singh and Arvind Ganesan embarked on a mission in... read more
24May
From legally blind to clear vision — thanks to eSight
Julissa Marquez, a eSight user and patient at the New York Eye and Ear Infirmary of Mount Sinai, says: “He... read more
28Sep
I Tried 18 Canned Wines — These Are the 7 Worth Drinking
Canned wines are often the most brilliant and low-waste alternative for when you just want a glass (or two) of... read more
08Jun
Emovi’s KneeKG Device Accepted to Smart Health Innovation Lab’s Certification Program, USA
Emovi, today announced that it has been selected to participate in a unique certification program at the newly-opened Smart Health... read more
19Apr
Pyramid Biosciences and GeneQuantum Healthcare Announce Preclinical Data for GQ1010, a Potential Best-In-Class TROP2-Targeted Antibody Drug Conjugate, at the 2023 AACR Annual Meeting
Pyramid Biosciences, Inc., a privately-held, clinical-stage biotechnology company focused on developing transformative medicines for patients with cancer, and its partner... read more
07Sep
Allergan Acquires Gene Therapy Company RetroSense Therapeutics Adding First-In-Class Technology to Company’s Innovative Eye Care Pipeline
llergan plc (NYSE: AGN), a leading global pharmaceutical company, and RetroSense Therapeutics LLC, a private, clinical-stage biotechnology company focused... read more
20Dec
DoggyStat rapidly resolves non-infectious canine diarrhea
Learn more about DoggyStat — an innovative product designed to resolve non-infectious diarrhea in dogs. Read more >>
read more
10Nov
OmniLife and ACTION Network Solidify Collaboration to Drive Innovation
OmniLife, a health technology communication and collaboration platform, has finalized its formal collaboration with the Advanced Cardiac Therapies Improving Outcomes... read more